VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $43.5M invested in Viridian Therapeutics in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$38.9M
2
+$1.31M
3
+$811K
4
Goldman Sachs
Goldman Sachs
New York
+$807K
5
DY
Dowling & Yahnke
California
+$498K

Top Sellers

1
-$53K
2
-$5K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$38.9M
2
$1.31M
3
$811K
4
$807K
5
$498K
6
$471K
7
$177K
8
$148K
9
$130K
10
$77K
11
$66K
12
$64K
13
$25K
14
$8K
15
$4K
16
$1K
17
–
18
–
19
–